期刊論文| 1. | 張琇碧(1984)。抗癌藥物調配和給藥的注意事項。中華民國癌症學會會刊，5(1)，5-8。 延伸查詢 |
| 2. | Harrison, Bruce R.(1981)。Developing guidelines for working with antineoplastic drugs。American Journal of Hospital Pharmacy，38(11)，1686-1693。  |
| 3. | Miller, S. A.(1987)。Issues in cytotoxic drug handling safety。Seminars in Oncology Nursing，3(2)，133-141。 |
| 4. | Selevan, S. G.、Lindbohm, M. L.、Hornang, R. W.(1985)。A study of occupational exposure to antineoplastic drugs and fetal loss in nurses。New England Journal of Medicine，313，1173-1178。 |
| 5. | Solimando, D. A.、Wilson, J. P.(1983)。Demonstration of skin fluorescence following exposure to doxorubincin。Cancer Nursing，6(6)，313-315。 |
| 6. | Vaccari, R. L.、Tonat, K.、Pechristoforo, R.、Galleli, J. F.、Eimmerman, P. F.(1984)。Disposal and antineoplastic wates at the National Institute of Health。American Journal of Hospital Pharmacy，41，87-93。 |
| 7. | Valanis. B.、Shortige, L.、Hertzberg, V.(1984)。Health hazards associated with work exposure to antineoplastic drugs (abstract)。American Journal Epidemology，120(3)，494。 |
| 8. | Venitt, S.、Croftron-Sleigh, C.、Hunt, J.(1984)。Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: Urinary mutation assays an urinary platinum as markers of absorption。Lancet，1(8368)，74-77。 |